University of Queensland
scientists say clinical trials for a
new dengue fever treatment could
start within 12 months, after they
identified similarities in how the
body reacts to dengue virus and
bacterial infections.
The dengue virus NS1 protein acts
as a toxin in the body in a similar
manner to the way bacterial cell
wall products lead to septic shock
in bacterial infections - meaning
existing drugs could possibly be repurposed
to treat dengue fever.The above article was sent to subscribers in Pharmacy Daily's issue from 11 Sep 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Sep 15
THE 87-year-old Amcal group has refreshed its brand tagline to ‘For you, for life’, as unveiled yesterday to over 240 members, suppliers and partners at the group’s national retail conference in Sydney.
AMID yesterday’s Amcal brand refresh announcement (see page one), parent company Sigma Healthcare is also readying for the 01 Jul start of its wholesale supply contract with Chemist Warehouse Group, worth at least $3 billion in revenue in the first full year (PD 06 Jun 2023).
OVER a quarter of a million people have sbeen vaccinated against influenza this year through community pharmacies in Queensland, reported the Pharmacy Guild of Australia.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.